Erin E Mulvihill
Overview
Explore the profile of Erin E Mulvihill including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
1857
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Morrow N, Morissette A, Mulvihill E
Peptides
. 2024 Mar;
176:171200.
PMID: 38555054
Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are peptide hormones produced by enteroendocrine cells in the small intestine. Despite being produced in the gut, the leveraging of their...
12.
13.
Tabatabaei Dakhili S, Yang K, Locatelli C, Saed C, Greenwell A, Chan J, et al.
Am J Physiol Cell Physiol
. 2023 Aug;
325(3):C750-C757.
PMID: 37575059
During periods of prolonged fasting/starvation, the liver generates ketones [i.e., β-hydroxybutyrate (βOHB)] that primarily serve as alternative substrates for ATP production. Previous studies have demonstrated that elevations in skeletal muscle...
14.
Fadzeyeva E, Locatelli C, Trzaskalski N, Nguyen M, Capozzi M, Vulesevic B, et al.
iScience
. 2023 May;
26(5):106748.
PMID: 37216093
Mice systemically lacking dipeptidyl peptidase-4 (DPP4) have improved islet health, glucoregulation, and reduced obesity with high-fat diet (HFD) feeding compared to wild-type mice. Some, but not all, of this improvement...
15.
Nunes J, Smith T, Ghorbani P, ODwyer C, Trzaskalski N, Dergham H, et al.
Am J Physiol Endocrinol Metab
. 2023 May;
325(1):E10-E20.
PMID: 37196059
Metabolic dysfunction-associated fatty liver disease (MAFLD) represents a growing cause of mortality and morbidity and encompasses a spectrum of liver pathologies. Although dozens of preclinical models have been developed to...
16.
Morrow N, Mulvihill E
J Pharmacol Exp Ther
. 2023 Mar;
385(1):1-4.
PMID: 36927510
No abstract available.
17.
Garneau L, Terada T, Mistura M, Mulvihill E, Reed J, Aguer C
Physiol Rep
. 2023 Mar;
11(5):e15634.
PMID: 36905198
Low-grade inflammation is central to coronary artery disease (CAD) and type 2 diabetes (T2D) and is reduced by exercise training. The objective of this study was to compare the anti-inflammatory...
18.
Castle A, Kang S, Eskandari-Sedighi G, Wohlgemuth S, Nguyen M, Drucker D, et al.
Proc Natl Acad Sci U S A
. 2022 Dec;
120(1):e2209815120.
PMID: 36574660
The cellular prion protein (PrP) converts to alternatively folded pathogenic conformations (PrP) in prion infections and binds neurotoxic oligomers formed by amyloid-β α-synuclein, and tau. β-Endoproteolysis, which splits PrP into...
19.
Basu L, Bhagat V, Ching M, Di Giandomenico A, Dostie S, Greenberg D, et al.
Can J Diabetes
. 2022 Dec;
47(2):207-221.
PMID: 36481263
Navigating the coronavirus disease-2019 (COVID-19, now COVID) pandemic has required resilience and creativity worldwide. Despite early challenges to productivity, more than 2,000 peer-reviewed articles on islet biology were published in...
20.
Trzaskalski N, Vulesevic B, Nguyen M, Jeraj N, Fadzeyeva E, Morrow N, et al.
JCI Insight
. 2022 Dec;
8(2).
PMID: 36472923
Elevated circulating dipeptidyl peptidase-4 (DPP4) is a biomarker for liver disease, but its involvement in gluconeogenesis and metabolic associated fatty liver disease progression remains unclear. Here, we identified that DPP4...